Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human Retinoic Acid Receptor alpha Antibodies:
anti-Mouse (Murine) Retinoic Acid Receptor alpha Antibodies:
anti-Rat (Rattus) Retinoic Acid Receptor alpha Antibodies:
Go to our pre-filtered search.
Human Monoclonal Retinoic Acid Receptor alpha Primary Antibody for EMSA, ICC - ABIN2668711
Reichrath, Mittmann, Kamradt, Müller: Expression of retinoid-X receptors (-alpha,-beta,-gamma) and retinoic acid receptors (-alpha,-beta,-gamma) in normal human skin: an immunohistological evaluation. in The Histochemical journal 1997
Show all 2 Pubmed References
Human Polyclonal Retinoic Acid Receptor alpha Primary Antibody for IHC (p), IHC - ABIN268790
Farias, Ong, Ghyselinck, Nakajo, Kuppumbatti, Mira y Lopez: Cellular retinol-binding protein I, a regulator of breast epithelial retinoic acid receptor activity, cell differentiation, and tumorigenicity. in Journal of the National Cancer Institute 2005
Human Monoclonal Retinoic Acid Receptor alpha Primary Antibody for IHC (p), ELISA - ABIN519635
Voss, Collin, Dixon, Thomas: Moz and retinoic acid coordinately regulate H3K9 acetylation, Hox gene expression, and segment identity. in Developmental cell 2009
Human Monoclonal Retinoic Acid Receptor alpha Primary Antibody for IHC (fro), WB - ABIN152363
Choi, Park, Sockanathan: Activated retinoid receptors are required for the migration and fate maintenance of subsets of cortical neurons. in Development (Cambridge, England) 2014
High RARA expression is associated with acute myeloid leukemia (show BCL11A Antibodies).
Data suggest that the binding of Z-10 to RXRalpha (show RXRA Antibodies) inhibited the interaction of RXRalpha (show RXRA Antibodies) with PML (show PML Antibodies)-RARalpha, leading to Z-10's selective induction of PML (show PML Antibodies)-RARalpha degradation.
PML (show PML Antibodies)-RARa bcr1 (show BCR Antibodies) fusion is not responsible for colorectal tumor development.
overexpression of NLS (show ALDH1A2 Antibodies)-RARalpha promoted the proliferation of APL (show FASL Antibodies) cells and inhibited their differentiation via the PI3K (show PIK3CA Antibodies)/AKT (show AKT1 Antibodies) signaling pathway.
r study demonstrated that ATRA cound promote differentiation while inhibit proliferation of acute promyelocytic leukemia (show PML Antibodies) NB4 cells via activating p38a (show MAPK14 Antibodies) protein after recruiting p38a (show MAPK14 Antibodies)-combinded NLS (show ALDH1A2 Antibodies)-RARa, while NLS (show ALDH1A2 Antibodies)-RARa could inhibit the effects of ATRA in the process.
Low expression of RARalpha was independently associated with worse progression-free survival following platinum-based chemotherapy of advanced Non-small cell lung cancer.
The classical counterpart of RARalpha, retinoid X receptor alpha (RXRalpha (show RXRA Antibodies)), was down-regulated in both cytoplasm and nucleus of A549 cells upon atRA addition.
RAI1 (show DOM3Z Antibodies) polymorphisms rs4925102 and rs9907986 are predicted to disrupt the binding of retinoic acid RXR-RAR receptors and the transcription factor DEAF1 (show DEAF1 Antibodies), respectively, in Smith-Magenis and Potocki-Lupski syndromes patients.
Data suggest that hematopoietically expressed homeobox protein (HHEX (show HHEX Antibodies)) downmodulation by promyelocytic leukemia (show PML Antibodies)-retinoic acid receptor alpha fusion oncoprotein (PML (show PML Antibodies)-RARalpha) is a key event during acute promyelocytic leukemia (show PML Antibodies) (APL (show FASL Antibodies)) pathogenesis.
ATRA dramatically down regulated RARalpha protein levels and led to more DNA damage and ultimately resulted in the synergism of these two agents
These data suggest that impairment of cardiac RARalpha signaling may be a novel mechanism that is directly linked to pathological stimuli-induced diastolic dysfunction.
Retinoic acid receptor alpha agonist all trans retinoic acid can protect the liver from ischemia reperfusion injury by promoting autophagy, which is dependent on Foxo3 (show FOXO3 Antibodies)/p-Akt (show AKT1 Antibodies)/Foxo1 (show FOXO1 Antibodies) signaling.
both the PML (show PML Antibodies)-RARA-driven competitive transplantation advantage and development of acute promyelocytic leukemia (show PML Antibodies) (APL (show FASL Antibodies)) required DNMT3A (show DNMT3A Antibodies)
the reprogramming of epiblast stem cells into embryonic stem cell-like cells also requires low levels of retinoic acid (RA), which can modulate Wnt (show WNT2 Antibodies) signalling through physical interactions of RARs (show RARS Antibodies) with beta-catenin (show CTNNB1 Antibodies).
our findings challenge the predominant model in the field and we propose that PML (show PML Antibodies)/RARA initiates leukemia by subtly shifting cell fate decisions within the promyelocyte compartment.
DNA-binding-defective PML (show PML Antibodies)/RARA mutants could not repress the transcription of retinoic acid regulated genes.
although X-RARA fusion proteins have been suggested to act by blocking retinoid-dependent transcriptional programs , we observed a surprising paucity of natural retinoids capable of transactivating Gal4 (show LGALS4 Antibodies)-RARA in primary mouse bone marrow cells
The results indicate a physiological role for RARgamma as a negative regulator of osteoclastogenesis in vivo and in vitro, and reveal distinct influences of RARalpha and RARgamma in bone structure regulation.
Data suggest that retinoic acid and GM-CSF (show CSF2 Antibodies)-induced retinal dehydrogenase 2 (RALDH2 (show ALDH1A2 Antibodies)) expression in dendritic cells requires cooperative binding of transcription factor Sp1 (show SP1 Antibodies) via the RA receptor/retinoid X receptor (show RXRB Antibodies) complex to the Aldh1a2 (show ALDH1A1 Antibodies) promoter.
Retinoic acid-RARalpha as a key component of the regulatory network governing maintenance and plasticity of Th1 (show HAND1 Antibodies)-cell fate.
Increased expression of mammary TRbeta1 (show THRB Antibodies) and DIO2 (show DIO2 Antibodies), and decreased RXRalpha (show RXRA Antibodies), provide a mechanism to increase thyroid hormone (show PTH Antibodies) activity within the mammary gland during lactation.
results show role for retinoic acid receptor (show RARB Antibodies) as a regulator of spatial patterning of the pre-placodal ectoderm (PPE)through Tbx1 and RIPPLY3; demonstrate that Ripply3, acting downstream of RAR (show RAB40B Antibodies) signaling, is key player in establishing boundaries in the PPE
This gene represents a nuclear retinoic acid receptor. The encoded protein, retinoic acid receptor alpha, regulates transcription in a ligand-dependent manner. This gene has been implicated in regulation of development, differentiation, apoptosis, granulopoeisis, and transcription of clock genes. Translocations between this locus and several other loci have been associated with acute promyelocytic leukemia. Alternatively spliced transcript variants have been found for this locus.
retinoic acid receptor alpha
, retinoic acid receptor, alpha
, retinoic acid receptor alpha-like
, nuclear receptor subfamily 1 group B member 1
, nucleophosmin-retinoic acid receptor alpha fusion protein NPM-RAR long form
, retinoic acid nuclear receptor alpha variant 1
, retinoic acid nuclear receptor alpha variant 2
, retinoic acid receptor, alpha polypeptide
, RAR alpha 1
, rar alpha
, xRAR alpha
, retinoic acid receptor alpha 1 isoform